Skip to main content
. Author manuscript; available in PMC: 2024 Feb 5.
Published in final edited form as: Vaccine. 2010 Dec 31;29(39):6763–6770. doi: 10.1016/j.vaccine.2010.12.055

Figure 2. Proliferative capacity of antigen specific T cells.

Figure 2.

Figure 2.

PBMCs from immunized macaques are stained with CFSE and stimulated with growth medium, concanavalin A (ConA), or SIV gag, SIV pol, or HIV Env peptides for 5 days. Following stimulation, cells were stained for phenotypic markers and analyzed by flow cytometry. A) Average proliferative capacity of CD4 and CD8 T cells B) Average for all primates is presented for CD4 or CD8 TCMs and TEMs. Data were acquired on an LSRI instrument analyzed with FlowJo software.